- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Caplin Point Laboratories Limited — Updates, 24-02-2026: Press Release
24-02-2026 | 12:40 pm
24-02-2026 | 12:40 pm
Caplin Point's subsidiary, Caplin Steriles, gained USFDA approval for Sodium Phosphates Injection. This generic drug competes in a US market with annual sales of approximately US$67 million, strengthening its regulated market footprint.
No comments yet. Be the first to comment!